Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study

Author： Park K.   Ahn C.   Bang B.K.   Kang C.M.   Kim S.I.   Kim S.J.   Kim Y.S.   Kim Y.S.   Koh Y.B.   Kwak J.Y.   Kwon O.J.   Moon I.S.   Moon J.I.   the Korean Tacrolimus Study Group  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.32, Iss.7, 2000-11, pp. : 1705-1708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)

By Cho D.K.   Kim J.H.   Park S.H.   Kim J.C.   Kim C.D.   Baek M.Y.   Kim S.J.   Kim S.H.   Kwon T.H.   Kim Y.L.   Kim Y.W.   Chang S.K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3256-3258

Elsevier

Access to resources Recommend Favorite

Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results

By Hodge E.E.   Reich D.J.   Clavien P.A.   Kim-Schluger L.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1546-1547

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

By Braun F.   Schutz E.   Peters B.   Talaulicar R.   Grupp C.   Undre N.   Schafer A.   Armstrong V.W.   Oellerich M.   Ringe B.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2127-2128

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

By Ciancio G.   Burke G.W.   Suzart K.   Vaidya A.   Roth D.   Kupin W.   Mattiazzi A.   Rosen A.   Esquenazi V.   Miller J.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 873-874

Elsevier

Access to resources Recommend Favorite

Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study

By Snydman D.R.   Falagas M.E.   Avery R.   Perlino C.   Ruthazer R.   Freeman R.   Rohrer R.   Fairchild R.   O'Rourke E.   Hibberd P.   Werner B.G.  

Transplantation Proceedings, Vol. 33, Iss. 4, 2001-06 ,pp. : 2571-2575

Elsevier

Access to resources Recommend Favorite